Sustainability Policy

About PODS Pharma

PODS Pharma is an international pharmaceutical company dedicated to advancing health and well-being. We develop and manufacture exclusively for human use, focusing on Pharmaceutical medicines, Active Pharmaceutical Ingredient(API), Nutraceutical solutions, Medical devices, and Medical consumables. Our portfolio covers both proprietary and generic medicines, together with innovative health solutions that support patient care and quality of life.

Our Approach and General Objectives

At PODS Pharma, we are committed to embedding sustainability across every aspect of our operations. Our priorities are:

• Environmental protection
• Social responsibility
• Ethical business conduct

Our overarching goal is to minimise our environmental footprint, promote well-being, uphold human rights, act with integrity, and ensure long-term resilience.

With our purpose of building well-being, we acknowledge the close connection between human health and the health of the planet. We recognise the interdependence of environmental and social sustainability and the long-term viability of our business.

We apply life-cycle thinking to evaluate our impacts not only within our own operations but across our entire value chain. We aim to create positive change for both people and the environment by adhering to the principles in this policy and fostering a culture of continuous improvement and innovation.

This policy is aligned with our Code of Conduct and our corporate values. It provides a governance framework for all PODS Pharma activities worldwide.

Social and Environmental Objectives

Respect for Human Rights

PODS Pharma respects and promotes human rights in line with the United Nations Guiding Principles on Business and Human Rights (UNGPs), the International Bill of Human Rights, the UN Convention on the Rights of the Child, and the ILO’s fundamental conventions.

• Respecting the rights of employees, workers, patients, consumers, and communities within our value chain.
• Continuously improving our due diligence processes, engaging affected stakeholders, and strengthening supply chain traceability.

Sustainability Due Diligence

• We identify, prevent, and mitigate risks of adverse impacts on people and the environment across our value chain.
• We use a risk-based approach, prioritising actions based on severity of potential or actual impacts.
• We build supply chain traceability, particularly for naturally derived raw materials.
• We engage actively with employees, communities, and end-users to identify impacts and design effective measures.

Commitment to Local Communities

PODS Pharma recognises that a healthy environment is essential for the fulfilment of economic, social, and cultural rights. We are committed to respecting and safeguarding the rights of local communities across our value chain.

Climate Action

• We support the Paris Agreement and accept the IPCC’s findings on human-driven climate change.
• We are committed to limiting global warming to 1.5°C and achieving net-zero emissions by 2050.
• We have set near-term climate targets validated by the Science Based Targets initiative (SBTi) and will decarbonise our operations this decade.

Sustainable Manufacturing and Environmental Stewardship

• We manufacture in ways that minimise environmental impact.
• We require all sites to manage waste and wastewater responsibly, even beyond local legal requirements.
• We work with suppliers to integrate responsible environmental practices into their operations.

Biodiversity Protection

• We recognise biodiversity loss as a crisis comparable to climate change.
• We are committed to ensuring no biodiversity loss caused by our operations or value chain.
• We promote sustainable sourcing and reduce impacts on endangered species.
• We take proactive measures to minimise pressures on ecosystems linked to our activities and supply chains.

Pharmaceuticals in the Environment and Antimicrobial Resistance (AMR)

• We acknowledge that pharmaceuticals may enter the environment during manufacturing and use.
• We assess, minimise, and manage environmental risks associated with pharmaceutical residues.
• We collaborate with others in the sector to develop science-based solutions.
• We actively work to prevent antimicrobial resistance by promoting responsible antibiotic use, preventive healthcare, and education.

Sustainable Water Use

• We recognise access to clean water as a fundamental human right.
• We commit to reducing water consumption across our operations and engaging suppliers in water-risk areas.
• We will improve efficiency and ensure responsible water management in research, development, and manufacturing.

Circular Economy and Resource Efficiency

• We embrace circular economy principles to reduce waste and maximise resource efficiency.
• We integrate sustainable design into product development and packaging, encouraging the use of renewable resources.
• We aim to minimise waste from the design stage through to end-of-life, without ever compromising patient safety.